Boulder-based biotech SomaLogic has entered a five-year partnership with the Food & Drug Administration

It can be very difficult to manufacture generic versions of biologic drugs. But SomaLogic has a test that can help determine whether a new drug candidate is similar enough to the original drug to be considered a generic.

Find out more in the Denver Business Journal article.

Categories: Ecosystem News